SCHEMBL20925737

SCHEMBL20925737

CC1(C)CCC2(C)CCC3C(C(=O)C=C4C5(C)C=C(C#N)C(=O)CC5CCC43C)C2C1

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ MBOAT4 Q96T53 6/20 0.44
▸ NOS2 P35228 6/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ KEAP1 Q14145 1/20 0.38
▸ NFE2L2 Q16236 2/20 0.37
▸ USP2 O75604 1/20 0.37
▸ STAT3 P40763 1/20 0.37
▸ USP7 Q93009 1/20 0.37
▸ RORC P51449 1/20 0.36
▸ CCR6 P51684 1/20 0.35
▸ CYP19A1 P11511 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23098192 0.95 MBOAT4 (0.46) MBOAT4NOS2CYP3A4CYP2C9CYP2C19
SCHEMBL20925915 0.89 NOS2 (0.37) MBOAT4NOS2CYP3A4CYP2C9CYP2C19
SCHEMBL20926037 0.89 NOS2 (0.37) MBOAT4NOS2CYP3A4CYP2C9CYP2C19
SCHEMBL20925901 0.89 NOS2 (0.39) MBOAT4NOS2CYP3A4CYP2C9CYP2C19
SCHEMBL20925889 0.89 NOS2 (0.37) MBOAT4NOS2CYP3A4CYP2C9CYP2C19
SCHEMBL20925960 0.87 MBOAT4 (0.36) MBOAT4NOS2CYP3A4CYP2C9CYP2C19
SCHEMBL20925742 0.86 NOS2 (0.39) MBOAT4NOS2CYP3A4CYP2C9CYP2C19
SCHEMBL20925948 0.86 NOS2 (0.50) MBOAT4NOS2CYP3A4CYP2C9CYP2C19
SCHEMBL20925918 0.86 NOS2 (0.37) MBOAT4NOS2CYP3A4CYP2C9CYP2C19
SCHEMBL20925749 0.86 NOS2 (0.42) MBOAT4NOS2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3353190-B1 C4-MODIFIED OLEANOLIC ACID DERIVATIVES FOR INHIBITION OF IL-17 AND OTHER USES REATA PHARMACEUTICALS INC (US) 2021-03-17 — — EP disclosed
EP-2683731-B1 C4-MONOMETHYL TRITERPENOID DERIVATIVES AND METHODS OF USE THEREOF REATA PHARMACEUTICALS INC (US) 2019-04-24 — — EP disclosed
Send feedback